Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 75, pseudogene (RN7SL75P)

Target
RN7SL75P
Molecular classification
Other (Pseudogene; non‐coding RNA pseudogene)
01

Overview

**RNA, 7SL, cytoplasmic 75, pseudogene (RN7SL75P)** is classified as a pseudogene in the human genome[6][7]. It belongs to a large family of 7SL RNA–like sequences that do not code for functional RNA and are the result of reverse transcription of the 7SL RNA gene back into DNA, often truncating at either end or in the middle[7]. Pseudogenes like RN7SL75P lack coding potential and biological activity; they do not code for proteins or functional RNAs and have no known physiological or pathological roles in humans[4][7]. They are not considered molecular targets for therapeutics, biomarkers, or clinical diagnostics. **Notes on Target Validity:** RN7SL75P is **not** a functional gene or molecule and is consequently **not considered a molecular target** for drugs or diagnostics. Being a pseudogene means it is a remnant of a functional gene, usually with lost or severely diminished function[4][7]. No interacting drugs, mechanism of action, or disease relevance are known for RN7SL75P. **Other Context:** The canonical, functional version of 7SL RNA (not the pseudogenes) is a critical component of the signal recognition particle, involved in co-translational targeting of secretory and membrane proteins, but RN7SL75P does not have these functions[1][3]. There are hundreds of such 7SL RNA–like pseudogenes in the human genome; RN7SL75P is one example without demonstrated biological activity[7][6].

Other names
RN7SL75P
02

Mechanism of action

None

03

Biological functions

None (pseudogene, not known to have biological function)
04

Disease associations

None (pseudogene, not implicated in disease)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 75, pseudogene (RN7SL75P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 75, pseudogene (RN7SL75P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call